JP2013510155A5 - - Google Patents

Download PDF

Info

Publication number
JP2013510155A5
JP2013510155A5 JP2012537925A JP2012537925A JP2013510155A5 JP 2013510155 A5 JP2013510155 A5 JP 2013510155A5 JP 2012537925 A JP2012537925 A JP 2012537925A JP 2012537925 A JP2012537925 A JP 2012537925A JP 2013510155 A5 JP2013510155 A5 JP 2013510155A5
Authority
JP
Japan
Prior art keywords
amino
alkyl
quinazolinyl
methyloxy
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012537925A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013510155A (ja
JP5836963B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/054927 external-priority patent/WO2011056740A1/en
Publication of JP2013510155A publication Critical patent/JP2013510155A/ja
Publication of JP2013510155A5 publication Critical patent/JP2013510155A5/ja
Application granted granted Critical
Publication of JP5836963B2 publication Critical patent/JP5836963B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012537925A 2009-11-03 2010-11-01 キナゾリン化合物 Expired - Fee Related JP5836963B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25764609P 2009-11-03 2009-11-03
US61/257,646 2009-11-03
PCT/US2010/054927 WO2011056740A1 (en) 2009-11-03 2010-11-01 Quinazoline compounds

Publications (3)

Publication Number Publication Date
JP2013510155A JP2013510155A (ja) 2013-03-21
JP2013510155A5 true JP2013510155A5 (enExample) 2013-12-19
JP5836963B2 JP5836963B2 (ja) 2015-12-24

Family

ID=43970282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012537925A Expired - Fee Related JP5836963B2 (ja) 2009-11-03 2010-11-01 キナゾリン化合物

Country Status (13)

Country Link
US (1) US8859571B2 (enExample)
EP (1) EP2501233B1 (enExample)
JP (1) JP5836963B2 (enExample)
KR (1) KR101736521B1 (enExample)
CN (1) CN102711474B (enExample)
AU (1) AU2010315361B2 (enExample)
BR (1) BR112012010524A2 (enExample)
CA (1) CA2779989A1 (enExample)
EA (1) EA021439B1 (enExample)
ES (1) ES2523465T3 (enExample)
IL (1) IL219504A (enExample)
MX (1) MX2012005155A (enExample)
WO (1) WO2011056740A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2398797B1 (en) * 2009-02-17 2013-11-06 Boehringer Ingelheim International GmbH Pyrimido[5,4-d]pyrimidine derivatives for the inhibition of tyrosine kinases
CN103159685A (zh) * 2013-04-11 2013-06-19 苏州立新制药有限公司 4-氯-6，7-二(2-甲氧基乙氧基)喹唑啉的制备方法
AU2014353006B2 (en) * 2013-11-20 2019-04-04 Signalchem Life Sciences Corp. Quinazoline derivatives as TAM family kinase inhibitors
CN105849044B (zh) 2013-12-26 2018-10-26 埃克森美孚研究工程公司 Zsm-48晶体的合成
CN111868039A (zh) * 2017-09-26 2020-10-30 加利福尼亚大学董事会 用于治疗癌症的组合物和方法
CN114521196A (zh) 2019-09-16 2022-05-20 诺华股份有限公司 双官能团降解剂及其使用方法
EP4405360A4 (en) 2021-09-23 2025-08-20 Erasca Inc POLYMORPHIC FORMS OF EGFR INHIBITOR

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9508565D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quiazoline derivative
EP2210607B1 (en) 2003-09-26 2011-08-17 Exelixis Inc. N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide for the treatment of cancer
JP5191391B2 (ja) * 2005-11-01 2013-05-08 ターゲジェン インコーポレーティッド キナーゼのビ−アリールメタ−ピリミジン阻害剤

Similar Documents

Publication Publication Date Title
JP2013510155A5 (enExample)
RU2497813C2 (ru) 4-(4-циано-2-тиоарил)-дигидропиримидиноны и их применение
RU2455288C2 (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
JP2014511869A5 (enExample)
JP2013510876A5 (enExample)
JP2014525937A5 (enExample)
RU2016136997A (ru) 2-(гет)арил-замещенные конденсированные бициклические гетероциклические производные в качестве пестицидов
JP2017530999A5 (enExample)
RU2018140092A (ru) Новые пиразолпиримидиновые производные
RU2012132692A (ru) Новые ингибиторы s-нитрозоглутатионредуктазы
RU2012112151A (ru) Соединения как модуляторы тирозинкиназы
JP2021503458A5 (enExample)
HRP20170112T1 (hr) Supstituirani spojevi piridin-2-karboksamida kao kinazni inhibitori signalne regulacije apoptoze
RU2016136116A (ru) Фармацевтические соединения
WO2012048181A4 (en) Novel substituted quinoline compounds as s-nitrosoglutathione reductase inhibitors
IL269710B2 (en) 2-oxo-thiazole derivatives as a2a inhibitors and compounds for use in cancer therapy
CY1107433T1 (el) Παραγωγα 1-(2η-πυραζολ-3-υλο)-3-(4-[1-(βενζοϋλο)-πιπepιδιν-4-υλομεθυλο]-φαινυλο)-ουριας και συναφεις ενωσεις ως αναστολεις της ρ38 κινασης και/ή tnf-αναστολεις για την αντιμετωπιση φλεγμονων
JP2017525757A5 (enExample)
JP2017522374A5 (enExample)
JP2017530185A5 (enExample)
KR20150135359A (ko) 브로모도메인-함유 단백질의 억제를 위한 방법 및 조성물
WO2010143074A3 (en) Pharmaceutical dosage form for oral administration of a bcl-2 family inhibitor
RU2007132262A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
MX2010006260A (es) Composiciones orales de abt-263 para tratar cancer.
CA2416874A1 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists